2'-hydroxyflavanone has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awasthi, S; Lelsani, P; Nagaprashantha, LD; Prokai, L; Singhal, J; Singhal, SS; Vatsyayan, R | 1 |
1 other study(ies) available for 2'-hydroxyflavanone and Angiogenesis, Pathologic
Article | Year |
---|---|
2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.
Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Carcinoma, Renal Cell; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Flavanones; Glutathione S-Transferase pi; Humans; Kidney Neoplasms; Mice; Mutation; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2011 |